TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup on October 18, 2026, of comments heard by its reporters on health research and policy. The quotes address AI in healthcare, access to a new mRNA flu shot, and studies involving pregnancy, transplantation, HIV and other topics; the roundup itself does not provide the underlying study details.
MedPage Today published a weekly roundup on October 18, 2026, collecting remarks from clinicians and researchers on artificial intelligence in healthcare, a new mRNA flu shot and several medical studies. The quotes offer snapshots of current discussions, but the roundup does not report the underlying research methods or results in detail.
The roundup’s technology comment came from Mishal Khan, PhD, of the UC Berkeley Labor Center, who said: “Tech is not good or bad, but neither is it neutral.” Khan was discussing artificial intelligence in healthcare. The brief item does not specify a particular AI system, its use case or the evidence behind the comment, so it should be read as a perspective on technology’s effects rather than a finding about a named product.
On access to the mRNA flu shot mFlusiva, Amesh Adalja, MD, of the Johns Hopkins Center for Health Security said people seeking it would have to use a website or call around. His remark points to possible practical barriers, but the roundup does not identify which providers offer the shot, explain its distribution arrangements or quantify how widely it is available.
The other quotations cover distinct topics. Krista Huybrechts of Brigham and Women’s Hospital described findings on benzodiazepine use early in pregnancy as reassuring while cautioning that the medicines are not risk-free. Ahmed Zayed of Staten Island University Hospital said pulmonary vascular resistance should not be interpreted in isolation when considering heart-transplant outcomes. Other comments addressed cancer risk in sickle cell disease, long-acting HIV treatment, and differences in health profiles among adolescents with similar body mass indexes.
Technology and Access in Focus
The selection connects clinical research with decisions that affect how care is delivered and accessed. Khan’s comment frames AI as a tool whose effects depend on how it is designed and used; Adalja’s remark highlights that availability can involve more than whether a treatment exists. These are attributed observations, not evidence that a specific technology or access policy has produced a measured outcome.
The clinical comments also illustrate why brief interpretations need careful qualification. Huybrechts paired reassurance about a study with a warning against treating benzodiazepines as risk-free. Zayed argued for interpreting one measure alongside other information. For readers, the practical takeaway is that the roundup captures expert perspectives, while decisions about treatment and risk require the full evidence and individual medical guidance.
As an affiliate, we earn on qualifying purchases.
Eight Topics in One Roundup
MedPage Today describes the item as a collection of quotable remarks heard by its reporters, rather than a single study or a unified report. The source lists eight comments from people affiliated with research institutions, hospitals or professional organizations. They concern healthcare AI, mFlusiva, the television show “The Swan,” pregnancy medication exposure, heart transplantation, sickle cell disease, HIV care and pediatric obesity screening.
That format matters: the comments refer to different studies and debates, and should not be treated as though they share one conclusion. The source gives speakers’ names and affiliations and brief descriptions of what they were discussing, but it does not include full interviews or links to the underlying research in the supplied material. The roundup was published October 18, 2026, and is labeled a two-minute read.
““Tech is not good or bad, but neither is it neutral.””
— Mishal Khan, PhD, UC Berkeley Labor Center
As an affiliate, we earn on qualifying purchases.
Evidence Behind the Remarks
The roundup does not provide study titles, sample sizes, methods or full results for the research mentioned. It is not possible from these excerpts alone to assess the strength of the findings on pregnancy medication exposure, transplant outcomes, cancer risk in sickle cell disease, HIV treatment or obesity screening.
Details about mFlusiva’s distribution and access are also absent, including eligibility, participating providers and whether the website or phone calls Adalja mentioned are the only routes to obtain it. The AI comment is similarly broad: the source does not say which healthcare uses, risks or benefits Khan had in mind. The quotes should not be taken as a substitute for the full studies or additional reporting.
pregnancy benzodiazepine safety guide
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Full Studies and Access Details
Readers seeking to evaluate any of the research should consult the original studies and their full findings, which are not reproduced in the supplied roundup. For questions about benzodiazepine use during pregnancy, flu vaccination or another treatment, patients should discuss their circumstances with a qualified healthcare professional rather than rely on a short quotation.
Further reporting or information from providers would be needed to clarify where and how mFlusiva can be obtained. The roundup does not announce a follow-up report, new policy or next research milestone, so whether additional details will be published remains unknown.
heart transplant pulmonary vascular resistance monitor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published a weekly collection of quotes from reporters’ conversations and coverage, dated October 18, 2026. The excerpts span healthcare technology, access and medical research.
What did the roundup say about AI in healthcare?
Mishal Khan of the UC Berkeley Labor Center said, “Tech is not good or bad, but neither is it neutral.” The source does not identify a specific AI tool or provide study results about one.
What is known about access to mFlusiva?
Amesh Adalja said people seeking the mRNA flu shot might need to use a website or call around. The roundup does not list providers, eligibility rules or broader availability details.
Does the roundup establish that benzodiazepines are safe in early pregnancy?
No. Huybrechts called the findings reassuring but also said benzodiazepines are not risk-free. The roundup does not include enough study detail to assess the evidence or apply it to an individual pregnancy.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
